These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 26097867)

  • 1. AID/APOBEC deaminases and cancer.
    Rebhandl S; Huemer M; Greil R; Geisberger R
    Oncoscience; 2015; 2(4):320-33. PubMed ID: 26097867
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA deaminases induce break-associated mutation showers with implication of APOBEC3B and 3A in breast cancer kataegis.
    Taylor BJ; Nik-Zainal S; Wu YL; Stebbings LA; Raine K; Campbell PJ; Rada C; Stratton MR; Neuberger MS
    Elife; 2013 Apr; 2():e00534. PubMed ID: 23599896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases.
    Conticello SG; Thomas CJ; Petersen-Mahrt SK; Neuberger MS
    Mol Biol Evol; 2005 Feb; 22(2):367-77. PubMed ID: 15496550
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolutionary effects of the AID/APOBEC family of mutagenic enzymes on human gamma-herpesviruses.
    Martinez T; Shapiro M; Bhaduri-McIntosh S; MacCarthy T
    Virus Evol; 2019 Jan; 5(1):vey040. PubMed ID: 30792902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the differential context-dependence of DNA deamination by APOBEC enzymes: correlation with mutation spectra in vivo.
    Beale RC; Petersen-Mahrt SK; Watt IN; Harris RS; Rada C; Neuberger MS
    J Mol Biol; 2004 Mar; 337(3):585-96. PubMed ID: 15019779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Somatic hypermutation in immunity and cancer: Critical analysis of strand-biased and codon-context mutation signatures.
    Steele EJ
    DNA Repair (Amst); 2016 Sep; 45():1-24. PubMed ID: 27449479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. APOBEC3 mutational signatures are associated with extensive and diverse genomic instability across multiple tumour types.
    Jakobsdottir GM; Brewer DS; Cooper C; Green C; Wedge DC
    BMC Biol; 2022 May; 20(1):117. PubMed ID: 35597990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of new driver and passenger mutations within APOBEC-induced hotspot mutations in bladder cancer.
    Shi MJ; Meng XY; Fontugne J; Chen CL; Radvanyi F; Bernard-Pierrot I
    Genome Med; 2020 Sep; 12(1):85. PubMed ID: 32988402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. APOBEC Enzymes: Mutagenic Fuel for Cancer Evolution and Heterogeneity.
    Swanton C; McGranahan N; Starrett GJ; Harris RS
    Cancer Discov; 2015 Jul; 5(7):704-12. PubMed ID: 26091828
    [TBL] [Abstract][Full Text] [Related]  

  • 10. AID expression in B-cell lymphomas causes accumulation of genomic uracil and a distinct AID mutational signature.
    Pettersen HS; Galashevskaya A; Doseth B; Sousa MM; Sarno A; Visnes T; Aas PA; Liabakk NB; Slupphaug G; Sætrom P; Kavli B; Krokan HE
    DNA Repair (Amst); 2015 Jan; 25():60-71. PubMed ID: 25486549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mapping clustered mutations in cancer reveals APOBEC3 mutagenesis of ecDNA.
    Bergstrom EN; Luebeck J; Petljak M; Khandekar A; Barnes M; Zhang T; Steele CD; Pillay N; Landi MT; Bafna V; Mischel PS; Harris RS; Alexandrov LB
    Nature; 2022 Feb; 602(7897):510-517. PubMed ID: 35140399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis.
    Shilova ON; Tsyba DL; Shilov ES
    Mol Biol; 2022; 56(1):46-58. PubMed ID: 35194245
    [TBL] [Abstract][Full Text] [Related]  

  • 13. AID and APOBEC deaminases: balancing DNA damage in epigenetics and immunity.
    Franchini DM; Petersen-Mahrt SK
    Epigenomics; 2014; 6(4):427-43. PubMed ID: 25333851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevated APOBEC mutational signatures implicate chronic injury in etiology of an aggressive head-and-neck squamous cell carcinoma: a case report.
    Patel J; den Breems NY; Tuluc M; Johnson J; Curry JM; South AP; Cho RJ
    J Med Case Rep; 2021 Apr; 15(1):252. PubMed ID: 33926553
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intrinsic immunity against retrotransposons by APOBEC cytidine deaminases.
    Koito A; Ikeda T
    Front Microbiol; 2013; 4():28. PubMed ID: 23431045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Generation of Genomic Alteration from Cytidine Deamination.
    Liu X; Meng FL
    Adv Exp Med Biol; 2018; 1044():49-64. PubMed ID: 29956291
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disruption of Transcriptional Coactivator Sub1 Leads to Genome-Wide Re-distribution of Clustered Mutations Induced by APOBEC in Active Yeast Genes.
    Lada AG; Kliver SF; Dhar A; Polev DE; Masharsky AE; Rogozin IB; Pavlov YI
    PLoS Genet; 2015 May; 11(5):e1005217. PubMed ID: 25941824
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The interesting relationship between APOBEC3 deoxycytidine deaminases and cancer: a long road ahead.
    Granadillo Rodríguez M; Flath B; Chelico L
    Open Biol; 2020 Dec; 10(12):200188. PubMed ID: 33292100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. APOBEC-mediated Mutagenesis as a Likely Cause of FGFR3 S249C Mutation Over-representation in Bladder Cancer.
    Shi MJ; Meng XY; Lamy P; Banday AR; Yang J; Moreno-Vega A; Chen CL; Dyrskjøt L; Bernard-Pierrot I; Prokunina-Olsson L; Radvanyi F
    Eur Urol; 2019 Jul; 76(1):9-13. PubMed ID: 30975452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA deamination in immunity: AID in the context of its APOBEC relatives.
    Conticello SG; Langlois MA; Yang Z; Neuberger MS
    Adv Immunol; 2007; 94():37-73. PubMed ID: 17560271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.